Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.99M Hold
16,034
1.78% 13
2024
Q1
$2.12M Hold
16,034
1.94% 10
2023
Q4
$1.75M Hold
16,034
1.61% 13
2023
Q3
$1.65M Hold
16,034
1.55% 16
2023
Q2
$1.85M Hold
16,034
1.68% 14
2023
Q1
$1.71M Sell
16,034
-5,654
-26% -$610K 1.61% 15
2022
Q4
$2.41M Hold
21,688
2.41% 7
2022
Q3
$1.87M Sell
21,688
-6,854
-24% -$612K 1.78% 11
2022
Q2
$2.6M Hold
28,542
2.64% 6
2022
Q1
$2.34M Hold
28,542
2.13% 11
2021
Q4
$2.19M Sell
28,542
-355
-1% -$28.3K 1.93% 14
2021
Q3
$2.17M Buy
28,897
+2,816
+11% +$214K 1.92% 14
2021
Q2
$2.03M Buy
+26,081
New +$1.94M 1.77% 17

Other funds holding MRK

EMFO LLC's MRK Position: Q2 2024 in Review

EMFO LLC held its Merck (MRK) position steady in Q2 2024 at 16,034 shares worth $1.99M. The position accounts for 1.78% of the portfolio, ranked #13.

EMFO LLC first reported a position in MRK in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.6M in Q2 2022. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • EMFO LLC held 16,034 shares of Merck worth $1.99M as of Q2 2024.
  • EMFO LLC left its Merck share count unchanged in Q2 2024.
  • Merck made up 1.78% of EMFO LLC's portfolio in Q2 2024, its #13 holding.
  • EMFO LLC first reported a position in Merck in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's Merck position peaked at $2.6M in Q2 2022.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.